HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

INA MVP Garlic, St. John's Wort Comparative Extracts Expected In September

This article was originally published in The Tan Sheet

Executive Summary

Validation methods and reference material samples for extracts of garlic (allicin) and St. John's wort (hyperforin) will be available in September from the Institute for Nutraceutical Advancement's Methods Validation Program, the group said.

You may also be interested in...



FDA Dietary Supplement Method Validation Manual Under Development

FDA is creating a Dietary Supplement Analytical Manual as part of an effort to identify and evaluate the most effective analytical methods and validation procedures for raw ingredients

CRN Action Plan Proactive Research Agenda-Setting Role Highlighted

The Council for Responsible Nutrition will take a more focused, proactive role in dietary supplement research by helping influence what types of studies are conducted, CRN VP-Science & Research Cathy Fomous, PhD, announced at the association's annual conference in Miami Sept. 17-20.

INA MVP Testing Methods To Encourage Botanicals Standardization

Analytical validation for the marker compounds terpene lactones in ginkgo biloba, lactones in kava kava, and flavonoids, hyperforin, hypericin and pseudohypericin in St. John's wort are being studied by member labs of the Institute for Nutraceutical Advancement's Methods Validation Program.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132753

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel